First City Capital Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-1,399
Closed -$234K 140
2019
Q2
$234K Sell
1,399
-330
-19% -$45.7K 0.17% 121
2019
Q1
$253K Sell
1,729
-175
-9% -$25.4K 0.18% 125
2018
Q4
$254K Sell
1,904
-1,350
-41% -$221K 0.2% 119
2018
Q3
$620K Hold
3,254
0.41% 80
2018
Q2
$543K Sell
3,254
-77
-2% -$12.4K 0.39% 82
2018
Q1
$561K Hold
3,331
0.42% 76
2017
Q4
$545K Buy
+3,331
New +$598K 0.37% 85
2016
Q2
Sell
-570
Closed -$153K 570
2016
Q1
$153K Hold
570
0.1% 154
2015
Q4
$178K Buy
+570
New +$170K 0.12% 138
2015
Q2
Sell
-200
Closed -$59.5K 637
2015
Q1
$59.5K Buy
200
+35
+21% +$9.98K 0.04% 258
2014
Q4
$42.5K Hold
165
0.03% 291
2014
Q3
$39.8K Buy
+165
New +$36.9K 0.03% 292

Other funds holding AGN

First City Capital Management's AGN Position: Q3 2019 in Review

First City Capital Management sold out of Allergan plc (AGN) in Q3 2019, closing a stake of 1,399 shares — an estimated $234K sold.

First City Capital Management first reported a position in AGN in Q3 2014 and held it in 12 quarters. The position peaked at $620K in Q3 2018. 921 funds tracked by Wall St. Rank hold AGN as of Q3 2019.

  • First City Capital Management reported no remaining Allergan plc position as of Q3 2019 after selling out during the quarter.
  • First City Capital Management sold 1,399 Allergan plc shares in Q3 2019, an estimated $234K.
  • First City Capital Management first reported a position in Allergan plc in Q3 2014 and held it in 12 quarters.
  • First City Capital Management's Allergan plc position peaked at $620K in Q3 2018.
  • 921 funds tracked by Wall St. Rank held Allergan plc as of Q3 2019.

Based on First City Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.